Author
Listed:
- Simon J. Beck
(The University of Texas at Dallas)
- Lan Guo
(The University of Texas at Dallas)
- Aarron Phensy
(School of Behavioral and Brain Sciences, The University of Texas at Dallas)
- Jing Tian
(The University of Texas at Dallas)
- Lu Wang
(The University of Texas at Dallas
Shandong Provincial Hospital Affiliated to Shandong University)
- Neha Tandon
(The University of Texas at Dallas)
- Esha Gauba
(The University of Texas at Dallas)
- Lin Lu
(The University of Texas at Dallas
Shandong Provincial Hospital Affiliated to Shandong University)
- Juan M. Pascual
(The University of Texas Southwestern Medical Center)
- Sven Kroener
(School of Behavioral and Brain Sciences, The University of Texas at Dallas)
- Heng Du
(The University of Texas at Dallas
Shandong Provincial Hospital Affiliated to Shandong University)
Abstract
F1FO-ATP synthase is critical for mitochondrial functions. The deregulation of this enzyme results in dampened mitochondrial oxidative phosphorylation (OXPHOS) and activated mitochondrial permeability transition (mPT), defects which accompany Alzheimer’s disease (AD). However, the molecular mechanisms that connect F1FO-ATP synthase dysfunction and AD remain unclear. Here, we observe selective loss of the oligomycin sensitivity conferring protein (OSCP) subunit of the F1FO-ATP synthase and the physical interaction of OSCP with amyloid beta (Aβ) in the brains of AD individuals and in an AD mouse model. Changes in OSCP levels are more pronounced in neuronal mitochondria. OSCP loss and its interplay with Aβ disrupt F1FO-ATP synthase, leading to reduced ATP production, elevated oxidative stress and activated mPT. The restoration of OSCP ameliorates Aβ-mediated mouse and human neuronal mitochondrial impairments and the resultant synaptic injury. Therefore, mitochondrial F1FO-ATP synthase dysfunction associated with AD progression could potentially be prevented by OSCP stabilization.
Suggested Citation
Simon J. Beck & Lan Guo & Aarron Phensy & Jing Tian & Lu Wang & Neha Tandon & Esha Gauba & Lin Lu & Juan M. Pascual & Sven Kroener & Heng Du, 2016.
"Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease,"
Nature Communications, Nature, vol. 7(1), pages 1-16, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11483
DOI: 10.1038/ncomms11483
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11483. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.